tiprankstipranks
Trending News
More News >
Psychemedics (PMDI)
OTHER OTC:PMDI
US Market

Psychemedics (PMDI) Price & Analysis

Compare
118 Followers

PMDI Stock Chart & Stats

$1.80
$0.10(4.88%)
At close: 4:00 PM EST
$1.80
$0.10(4.88%)

PMDI FAQ

What was Psychemedics’s price range in the past 12 months?
Psychemedics lowest stock price was $1.11 and its highest was $2.70 in the past 12 months.
    What is Psychemedics’s market cap?
    Psychemedics’s market cap is $10.26M.
      When is Psychemedics’s upcoming earnings report date?
      Psychemedics’s upcoming earnings report date is Aug 12, 2025 which is 129 days ago.
        How were Psychemedics’s earnings last quarter?
        Currently, no data Available
        Is Psychemedics overvalued?
        According to Wall Street analysts Psychemedics’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Psychemedics pay dividends?
          Psychemedics does not currently pay dividends.
          What is Psychemedics’s EPS estimate?
          Psychemedics’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Psychemedics have?
          Psychemedics has 6,109,502 shares outstanding.
            What happened to Psychemedics’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Psychemedics?
            Currently, no hedge funds are holding shares in PMDI
            What is the TipRanks Smart Score and how is it calculated?
            Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

              Company Description

              Psychemedics

              Psychemedics Corp. engages in the provision of drug testing services through the analysis of hair samples. It specializes in a five panel drug testing process for cocaine, opioids, Phenyclidine, amphetamines, and marijuana. It offers workplace, school, and personal drug testing services. The company was founded by Werner Baumgartner and Annette Baumgartner on September 24, 1986 and is headquartered in Acton, MA.

              Psychemedics (PMDI) Earnings & Revenues

              Similar Stocks
              Company
              Price & Change
              Follow
              Imunon
              TherapeuticsMD
              EKSO BIONICS
              Marker Therapeutics
              bioAffinity Technologies, Inc.

              Ownership Overview

              38.48%4.52%57.00%
              38.48%
              Insiders
              4.52% Other Institutional Investors
              57.00% Public Companies and
              Individual Investors

              Options Prices

              Currently, No data available
              ---
              Popular Stocks